4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-033740
Options or other derivatives
- Director acquired 27,245 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tessier-Lavigne Marc Director | 2019-05-30 | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | D | ||
Loading xslF345X03/doc4.xml…